Is Electrical Brain Activity a Reliable Biomarker for Opioid Analgesia in the Gut?

Basic and Clinical Pharmacology and Toxicology

Volumn 109, Issue 5, 2011, Pages 321-327

  Staahl, Camilla ^a,b   Krarup, Anne L ^a   Olesen, Anne E ^a,b   Brock, Christina ^a,b   Graversen, Carina ^a   Drewes, Asbjørn M ^a,b  

^a AALBORG UNIVERSITY HOSPITAL   (Denmark)

^b AALBORG UNIVERSITY   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

MORPHINE; PLACEBO;

ADULT; ANALGESIA; ARTICLE; BRAIN ELECTROPHYSIOLOGY; CINGULATE GYRUS; CONTROLLED STUDY; CROSSOVER PROCEDURE; DIPOLE; DOUBLE BLIND PROCEDURE; ELECTROENCEPHALOGRAPHY; FEMALE; GASTROINTESTINAL PAIN; HUMAN; MALE; MULTICHANNEL EVOKED BRAIN POTENTIAL; ORANGE JUICE; PAIN ASSESSMENT; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RELIABILITY; VISUAL ANALOG SCALE;

ADULT; ANALGESICS; ANALGESICS, OPIOID; BIOLOGICAL MARKERS; BRAIN; CROSS-OVER STUDIES; DOUBLE-BLIND METHOD; ESOPHAGUS; EVOKED POTENTIALS; GASTROESOPHAGEAL REFLUX; GASTROINTESTINAL TRACT; HUMANS; MALE; MIDDLE AGED; MORPHINE; NERVOUS SYSTEM PHYSIOLOGICAL PHENOMENA; PAIN MEASUREMENT; PAIN THRESHOLD; REPRODUCIBILITY OF RESULTS; YOUNG ADULT;

EID: 80054055429     PISSN: 17427835     EISSN: 17427843     Source Type: Journal    
DOI: 10.1111/j.1742-7843.2011.00727.x     Document Type: Article

References (49)

1. Chizh BA, Priestley T, Rowbotham M, Schaffler K. Predicting therapeutic efficacy - experimental pain in human subjects. Brain Res Rev 2009;60:243-54.
2. Coda B, Tanaka A, Jacobson RC, Donaldson G, Chapman CR. Hydromorphone analgesia after intravenous bolus administration. Pain 1997;71:41-8.
3. Petersen-Felix S, Arendt-Nielsen L, Bak P, Fischer M, Zbinden AM. Psychophysical and electrophysiological responses to experimental pain may be influenced by sedation: comparison of the effects of a hypnotic (propofol) and an analgesic (alfentanil). Br J Anaesth 1996;77:165-71.
4. Quante M, Scharein E, Zimmermann R, Langer-Brauburger B, Bromm B. Dissociation of morphine analgesia and sedation evaluated by EEG measures in healthy volunteers. Arzneimittelforschung 2004;54:143-51.
5. Schmidt GN, Scharein E, Siegel M, Muller J, Debener S, Nitzschke R et al. Identification of sensory blockade by somatosensory and pain-induced evoked potentials. Anesthesiology 2007;106:707-14.
6. Chou R, Fanciullo GJ, Fine PG, Adler JA, Ballantyne JC, Davies P et al. Clinical guidelines for the use of chronic opioid therapy in chronic noncancer pain. J Pain 2009;10:113-30.
7. Dickenson AH, Le BD. Supraspinal morphine and descending inhibitions acting on the dorsal horn of the rat. J Physiol 1987;384:81-107.
8. Treede RD, Kenshalo DR, Gracely RH, Jones AK. The cortical representation of pain. Pain 1999;79:105-11.
9. Price DD, Von der GA, Miller J, Rafii A, Price C. A psychophysical analysis of morphine analgesia. Pain 1985;22:261-9.
10. Sprenger T, Valet M, Boecker H, Henriksen G, Spilker ME, Willoch F et al. Opioidergic activation in the medial pain system after heat pain. Pain 2006;122:63-7.
11. Drewes AM, Schipper KP, Dimcevski G, Petersen P, Andersen OK, Gregersen H et al. Multi-modal induction and assessment of allodynia and hyperalgesia in the human oesophagus. Eur J Pain 2003;7:539-49.
12. Grech R, Cassar T, Muscat J, Camilleri KP, Fabri SG, Zervakis M et al. Review on solving the inverse problem in EEG source analysis. J Neuroeng Rehabil 2008;5:25.
13. Fuchs M, Ford MR, Sands S, Lew HL. Overview of dipole source localization. Phys Med Rehabil Clin N Am 2004;15:251-62.
14. Brown WS, Marsh JT, Smith JC. Principal component analysis of ERP differences related to the meaning of an ambiguous word. Electroencephalogr Clin Neurophysiol 1979;46:709-14.
15. Michel CM, Murray MM, Lantz G, Gonzalez S, Spinelli L, Grave de PR. EEG source imaging. Clin Neurophysiol 2004;115:2195-222.
16. Mosher JC, Baillet S, Leahy RM. EEG source localization and imaging using multiple signal classification approaches. J Clin Neurophysiol 1999;16:225-38.
17. Skrandies W. EEG/EP: new techniques. Brain Topogr 1993;5:347-50.
18. Hobson AR, Hillebrand A. Independent component analysis of the EEG: is this the way forward for understanding abnormalities of brain-gut signalling? Gut 2006;55:597-600.
19. Staahl C, Olesen AE, Andresen T, Arendt-Nielsen L, Drewes AM. Assessing analgesic actions of opioids by experimental pain models in healthy volunteers - an updated review. Br J Clin Pharmacol 2009;68:149-68.
20. Dimcevski G, Sami SA, Funch-Jensen P, Le Pera D, Valeriani M, Arendt-Nielsen L et al. Pain in chronic pancreatitis: the role of reorganization in the central nervous system. Gastroenterology 2007;132:1546-56.
21. Drewes AM, Sami SA, Dimcevski G, Nielsen KD, Funch-Jensen P, Valeriani M et al. Cerebral processing of painful oesophageal stimulation: a study based on independent component analysis of the EEG. Gut 2006;55:619-29.
22. Drewes AM, Dimcevski G, Sami SA, Funch-Jensen P, Huynh KD, Le Pera D et al. The "human visceral homunculus" to pain evoked in the oesophagus, stomach, duodenum and sigmoid colon. Exp Brain Res 2006;174:443-52.
23. Hobson AR, Furlong PL, Sarkar S, Matthews PJ, Willert RP, Worthen SF et al. Neurophysiologic assessment of esophageal sensory processing in noncardiac chest pain. Gastroenterology 2006;130:80-8.
24. Yang M, Li ZS, Xu XR, Fang DC, Zou DW, Xu GM et al. Characterization of cortical potentials evoked by oesophageal balloon distention and acid perfusion in patients with functional heartburn. Neurogastroenterol Motil 2006;18:292-9.
25. Hobson AR, Furlong PL, Worthen SF, Hillebrand A, Barnes GR, Singh KD et al. Real-time imaging of human cortical activity evoked by painful esophageal stimulation. Gastroenterology 2005;128:610-9.
26. Garcia-Larrea L, Frot M, Valeriani M. Brain generators of laser-evoked potentials: from dipoles to functional significance. Neurophysiol Clin 2003;33:279-92.
27. Derbyshire SW, Whalley MG, Stenger VA, Oakley DA. Cerebral activation during hypnotically induced and imagined pain. Neuroimage 2004;23:392-401.
28. Yaguez L, Coen S, Gregory LJ, Amaro E Jr, Altman C, Brammer MJ et al. Brain response to visceral aversive conditioning: a functional magnetic resonance imaging study. Gastroenterology 2005;128:1819-29.
29. Fulbright RK, Troche CJ, Skudlarski P, Gore JC, Wexler BE. Functional MR imaging of regional brain activation associated with the affective experience of pain. AJR Am J Roentgenol 2001;177:1205-10.
30. Mayer EA, Berman S, Suyenobu B, Labus J, Mandelkern MA, Naliboff BD et al. Differences in brain responses to visceral pain between patients with irritable bowel syndrome and ulcerative colitis. Pain 2005;115:398-409.
31. Wagner KJ, Sprenger T, Kochs EF, Tolle TR, Valet M, Willoch F. Imaging human cerebral pain modulation by dose-dependent opioid analgesia: a positron emission tomography activation study using remifentanil. Anesthesiology 2007;106:548-56.
32. Schleim S, Roiser JP. FMRI in translation: the challenges facing real-world applications. Front Hum Neurosci 2009;3:63.
33. Hobson AR, Aziz Q. Brain imaging and functional gastrointestinal disorders: has it helped our understanding? Gut 2004;53:1198-206.
34. Hollerbach S, Fitzpatrick D, Shine G, Kamath MV, Upton AR, Tougas G. Cognitive evoked potentials to anticipated oesophageal stimulus in humans: quantitative assessment of the cognitive aspects of visceral perception. Neurogastroenterol Motil 1999;11:37-46.
35. Premkumar LS. Targeting TRPV1 as an alternative approach to narcotic analgesics to treat chronic pain conditions. AAPS J 2010;12:361-70.
36. Strigo IA, Bushnell MC, Boivin M, Duncan GH. Psychophysical analysis of visceral and cutaneous pain in human subjects. Pain 2002;97:235-46.
37. Christensen J. Origin of sensation in the esophagus. Am J Physiol 1984;246:G221-5.
38. Kofke WA, Blissitt PA, Rao H, Wang J, Addya K, Detre J. Remifentanil-induced cerebral blood flow effects in normal humans: dose and ApoE genotype. Anesth Analg 2007;105:167-75.
39. Kuo CC, Chiou RJ, Liang KC, Yen CT. Differential involvement of the anterior cingulate and primary sensorimotor cortices in sensory and affective functions of pain. J Neurophysiol 2009;101:1201-10.
40. Oertel BG, Preibisch C, Wallenhorst T, Hummel T, Geisslinger G, Lanfermann H et al. Differential opioid action on sensory and affective cerebral pain processing. Clin Pharmacol Ther 2008;83:577-88.
41. Westlund KN, Vera-Portocarrero LP, Zhang L, Wei J, Quast MJ, Cleeland CS. fMRI of supraspinal areas after morphine and one week pancreatic inflammation in rats. Neuroimage 2009;44:23-34.
42. van der Kam EL, Vry JD, Schiene K, Tzschentke TM. Differential effects of morphine on the affective and the sensory component of carrageenan-induced nociception in the rat. Pain 2008;136:373-9.
43. Bouhassira D, Villanueva L, Le Bars D. Effects of systemic morphine on diffuse noxious inhibitory controls: role of the periaqueductal grey. Eur J Pharmacol 1992;216:149-56.
44. Le Bars D, Willer JC, De BT. Morphine blocks descending pain inhibitory controls in humans. Pain 1992;48:13-20.
45. Willer JC, Le Bars D, De BT. Diffuse noxious inhibitory controls in man: involvement of an opioidergic link. Eur J Pharmacol 1990;182:347-55.
46. Ohara S, Anderson WS, Lawson HC, Lee HT, Lenz FA. Endogenous and exogenous modulators of potentials evoked by a painful cutaneous laser (LEPs). Acta Neurochir Suppl 2006;99:77-9.
47. Rios M, Treede R, Lee J, Lenz FA. Direct evidence of nociceptive input to human anterior cingulate gyrus and parasylvian cortex. Curr Rev Pain 1999;3:256-64.
48. Kuo CC, Yen CT. Comparison of anterior cingulate and primary somatosensory neuronal responses to noxious laser-heat stimuli in conscious, behaving rats. J Neurophysiol 2005;94:1825-36.
49. Stephenson DT, Arneric SP. Neuroimaging of pain: advances and future prospects. J Pain 2008;9:567-79.